Abstract
The article analyzes the role of Protestant moral reformers and pharmaceutical entrepreneurs in the United States in defining drug control policies in the early 20th century from the perspective of global history. It focusses on the reformer Richmond Hobson and the businessman Josiah K. Lilly, to study the influence of both sectors and characters on the construction of the international drug prohibitionist system, in which semantics was key.
The author concludes that the division of the drug market into legal and illegal drugs after the Great War yielded enormous benefits for the pharmaceutical sector in developed countries, to the detriment of the well-being and human rights of most of the world’s population.
References
Fuentes documentales:
• National Library of Medicine, National Institutes of Health, The Kolb Papers.
• Library of Congress, The Hobson Papers y The Ellen LaMotte Papers.
• The New York Times (NYT), Historical Archive.
Bibliografía
• Astorga, Luis, (2007). Seguridad, traficantes y militares. (El Poder y la sombra), México: Tusquet).
• Autrique Escobar, Cecilia, (2020). “Salvar a la raza”. La prohibición del alcohol, los protestantes de Estados Unidos y los revolucionarios de México (1916-1933), México: Universidad Iberoamericana.
• Bodenhamer David et al, (1994). The Encyclopedia of Indianapolis, Indianapolis: Indianapolis University Press.
• Bolaños, Ricardo, coord. (2014), Psicotrópicos y estupefacientes. Visión Farmacológica y normativa, Argentina: Administración Nacional de Medicamentos, Alimentos y Tecnología Médica, recuperado en http://www.anmat.gov.ar/ssce/libro-psicotropicos-estupefacientes.pdf
• Charles, Molly “United Nations Demand Reduction. A Success Biased Perception”, en Juan Gabriel Tokatlian, ed. (2010). Drugs and Prohibition, An Old War, A New Debate, Buenos Aires: Libros del Zoral.
• Davenport, David, (2003). La búsqueda del olvido. Historia global de las drogas, 1500-2000, Fondo de Cultura Económica.
• Díaz Cuervo, Jorge, (2016). Drogas. Caminos hacia la legalización, México: Editorial Ariel.
• Escohotado, Antonio, (1989). Historia de las drogas, tomo II, Madrid: Alianza Editorial de Bolsillo.
• Gootenberg, Paul, (2008). Andean Cocaine. The Making of a Global Drug, Chapel Hill: University of North Carolina Press.
• Herzberg, David, (2020). White Market Drugs. Big Pharma and the Hidden History of Addiction in America, Chicago: University of Chicago Press.
• Kahn, E.J., (c.1975). All In A Century. The First Hundred Years of Eli Lilly and Company, Indianápolis: edición limitada, sin documentar.
• Musto, David, (1999). The American Disease. Origins of Narcotic Control, Nueva York: Oxford University Press.
• Pennant Rupert et. al., (1983). Pocket Economist, Londres: The Economist, 2ª edición.
• Pérez Montfort, Ricardo (2016). Tolerancia y prohibición. Aproximaciones a la historia social y cultural de las Drogas 1840-1940. México: Editorial Penguin Random House.
• Reiss, Susanna, (2014). We Sell Drugs. The Alchemy of US Empire, Oakland: University of California Press.
• Rosenfeld, Harvey, (2001). Richmond Pearson Hobson, Naval Hero from Magnolia Grove, New Mexico: Yuca Tree Press.
• Tyrrell, Ian, (2010). Reforming the World. The Creation of America’s Moral Empire, Princeton: Princeton University Press.
• Walker, William O., (1989). Drug Control in the Americas, Alburquerque: Universidad de Nuevo Mexico, 2ª edición.
Artículos
• Autrique, Cecilia, (julio-diciembre 2019). Los orígenes de los movimientos prohibicionistas del alcohol y las drogas. El caso de México (1917-1928). Historia y grafía, México, Universidad Iberoamericana, (53), 148-168.
• Block, Fred, (febrero 1977). Beyond Corporate Liberalism. Social Problems, 24, (3), 352-261.
• Burke-Shyne, Nao I., (junio 2017). How Drug Control Policy and Practice Undermine Access to Controlled Medicines. Health and Human Rights, 237-252.
• Charles, Molly, (2010). United Nations Drug Demand Reduction, a Success or A Biased Perception. Juan Gabriel Tokatliian (Ed). Drugs and Prohibition. An Old War, A New Debate. (pp. 53-96), Buenos Aires, Libros del Zorzal.
• Cramer, Tobias, (Spring 2015). Building the “World´s Pharmacy”: The Rise of German Pharmaceutical Industry. The Business History Review, 89, (1), 43-73.
• Collins, William J. (1919). The International Control of Drugs of Addiction. The Present Position of The International Opium Convention, 1912. The British Medical Journal (2), (3064), 369-70.
• Corona, Liliana, Eli Lilly cumple 100 años de presencia en México, Expansión, 21 de marzo de 2018, en https://expansion.mx/empresas/2018/03/21/eli-lilly-cumple-110-anos-de-presencia-en-mexico
• Del Rio, Richard, (2019), Expanding Our Scope: Pharmaceuticals and Criminal Justice. Pharmacy in History, 61, (3-4), 140-143.
• Gabriel, Joseph. (Julio 2010). Restricting the Sale of “Deadly Poisons”: Pharmacists, Drug Regulation, and Narratives of Suffering in the Gilded Age. The Journal of the Gilded Age and Progressive Era, 9, (3), 315-318.
• Gene E. McCormick, (1970). Josiah Kirby Lilly, Sr., the Man (1861-1948).
Pharmacy in History, 12, (2), 57-67.
• Madison, James H., (1989). Manufacturing Pharmaceuticals: Eli Lilly and Company, 1876-1948. Business and Economic History, (18), 72-78.
• McCarthy, Robert. The History of American Pharmacy. American Institute of the History of Pharmacy. University of Wisconsin-Madison School of Medicine, https://aihp.org/historical-resources
• Speaker, Susan, (Primavera 2001). The Struggle of Mankind against Its Deadliest Foe: Themes of Counter-Subversion in Anti-Narcotic Campaigns, 1920-1940. Journal of Social History, 34, (3), 591- 610.
Fuentes electrónicas
• Eli Lilly Papers (1937-1961), Indiana Historic Society, https://indianahistory.org/wp-content/uploads/eli-lilly-papers-1937-1961.pdf
• Indianapolis Monthly Magazine, indianapolismonthly.com
• McCarthy, Robert. The History of American Pharmacy. American Institute of the History of Pharmacy. University of Wisconsin-Madison School of Medicine, https://aihp.org/historical-resources
• Temperance and Prohibition. Ohio State University, https://prohibition.osu.edu/hobson
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Copyright (c) 2023 Cecilia Autrique Escobar